CasNo.42461-84-7,Veterinary Medicines Animal Analgesic Flunixin Meglumine,(42461-84-7) Suppliers

1 Kilogram	FOB Price:USD 4.8000 -5.0000

Min.Order :1 Kilogram
Purity: 99%
Payment Terms : L/C,D/A,D/P,T/T,Other

Keywords

Flunixin Meglumine 42461-84-7 Flunixin Meglumine powder

Quick Details

Appearance:White powder
Application:Blood lipid regulation, anti - atherosclerosis drugs
PackAge:25KG/DRUM
ProductionCapacity:1000|Kilogram|Year
Storage:Store at +4°C
Transportation:General cargo transport

Superiority:

We are concentrating on APIs and pharmaceutical intermediates.

It is made obtainable from us at the most reasonable rate.

Our Service:

1. Rich experience: Our company is a professional production leading factory in China in pharmaceutical area of manyyears.

2. Top quality: High quality guaranteed, once any problem is found, the package would be reshipped for you .

3. Security Shipping: Shipping by express (FedEx,UPS,DHL,EMS), by air, by sea. The most professional forwarder would be recommanded for you.

4. Fast delivery: We have stock, so we can delivery quickly once payment is received.

5. Quality service: We will give you warm after-sale service,if any question we will reply you within 24 hours.

6. Competitive prices: A discount would be given when you make a large order.

Details:

Company Profile:

Company name: Hanways ChemPharm Co., Ltd.

Year Establishment: 2009

Location: 18-1-802, Green Garden, Jianghan District, Wuhan 430023, China

Main product:
- API: Antiobesity; Oncology; Antiviral; Cardiovascular; Antibiotics; Antidiabetics and others
- Peptides
- Hormones
- Intermediates

Product Name: Flunixin Meglumine

CAS: 42461-84-7

MF: C21H28F3N3O7

MW: 491.46

EINECS: 255-836-0

Appearance: White powder

In the United States, flunixin meglumine is approved for use in horses, cattle and swine; however, it is approved for use in dogs in other countries. The approved indications for its use in the horse are for the alleviation of inflammation and pain associated with musculoskeletal disorders and alleviation of visceral pain associated with colic. In cattle it is approved for the control of pyrexia associated with bovine respiratory disease and endotoxemia, and control of inflammation in endotoxemia. In swine, flunixin is approved for use to control pyrexia associated with swine respiratory disease.

Flunixin has been suggested for many other indications in various species, including: Horses: foal diarrheas, shock, colitis, respiratory disease, post-race treatment, and pre- and post ophthalmic and general surgery; Dogs: disk problems, arthritis, heat stroke, diarrhea, shock, ophthalmic inflammatory conditions, pre- and post ophthalmic and general surgery, and treatment of parvovirus infection; Cattle: acute respiratory disease, acute coliform mastitis with endotoxic shock, pain (downer cow), and calf diarrheas; Swine: agalactia/hypogalactia, lameness, and piglet diarrhea. It should be noted that the evidence supporting some of these indications is equivocal and flunixin may not be appropriate for every case.